Non-interventional Study for Real-world Data of Afatinib Treatment in First-line Setting and of Subsequent Therapies for Patients With Advanced Epidermal Growth Factor Receptor (EGFR) Mutation-positive Lung Adenocarcinoma
Clinical trial NCT04795245 · COMPLETED
Trial details
- NCT number
- NCT04795245
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-08-26
- Primary completion
- 2023-10-16
- Enrollment
- 805
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.